Agents for Detecting and Imaging Cell Death
This invention relates to molecular imaging agents comprising an S78C mutant synaptotagmin I C2A domain. These agents may be useful in detecting or assessing cell death in vitro and in vivo, for example in tumours following cancer treatment.
Patents:US 20,110,038,798
Inventor(s):
BRINDLE KEVIN [GB]; NEVES ANDRE [GB]; DE BACKER MAAIKE [NL]; ALAM ISRAT [GB]
Type of Offer:
Sale
« More Biotech Patents